Human CD34 as a biomarker and functional tool in progenitor cell isolation: A comprehensive review

CD34, a heavily glycosylated transmembrane sialomucin encoded on chromosome 1q32, has served as the preeminent cell surface marker for identifying and isolating hematopoietic stem and progenitor cells (HSPCs) since its initial characterization in 1984 (1). This comprehensive review examines the expression patterns, biological functions, and clinical applications of human CD34 across the hematopoietic hierarchy, from primitive long-term repopulating hematopoietic stem cells (HSCs) through lineage-committed progenitors including multipotent progenitors (MPPs), common myeloid progenitors (CMPs), granulocyte-monocyte progenitors (GMPs), megakaryocyte-erythroid progenitors (MEPs), and common lymphoid progenitors (CLPs). Beyond hematopoietic cells, CD34 expression extends to endothelial progenitor cells (EPCs), fibrocytes, and various tissue-specific progenitor populations, underscoring its broad significance in stem cell biology and regenerative medicine (2). A critical focus of this review addresses the labile nature of CD34 protein expression, which poses significant challenges for accurate quantification in clinical applications, particularly in the context of hematopoietic stem cell transplantation. This review synthesizes current understanding of CD34 biology across progenitor populations, examines quantitative aspects of protein stability during ex vivo manipulation, discusses strategies to minimize CD34 loss during cryopreservation, and evaluates emerging alternative markers and functional assays that may complement or supplement CD34-based approaches in both research and clinical settings.